Abivax S.A. Income Statement

Income Statement Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.01B0.00B0.00B0.01B
Gross Profit 0.01B0.00B0.00B0.01B
Operating items
Research & Development 0.06B0.05B0.11B0.16B
Selling, General & Administrative 0.01B0.01B0.02B0.04B
Other Operating Expenses 0.01B0.01B0.01B
Operating Expenses 0.06B0.07B0.14B0.20B
Operating Income -0.05B-0.07B-0.14B-0.18B
EBIT -0.05B-0.07B-0.14B-0.18B
Non-operating items
Interest & Investment Income 0.00B0.01B0.01B0.01B
Non Operating Income -0.00B0.00B-0.02B0.06B
Net income details
EBT -0.05B-0.06B-0.16B-0.19B
Profit After Tax -0.05B-0.06B-0.16B-0.19B
Income from Continuing Operations -0.05B-0.06B-0.16B-0.19B
Consolidated Net Income -0.05B-0.06B-0.16B-0.19B
Income towards Parent Company -0.05B-0.06B-0.16B-0.19B
Net Income towards Common Stockholders -0.05B-0.06B-0.16B-0.19B
Additional items
EPS (Basic) -0.00B-0.00B-0.00B-0.00B
EPS (Weighted Average and Diluted) -0.00B-0.00B-0.00B-0.00B
Shares Outstanding (Weighted Average) 0.04B0.06B0.06B
Shares Outstanding (Diluted Average) 0.02B0.02B0.05B0.07B
EBITDA -0.05B-0.07B-0.14B-0.18B
Shares Outstanding 67.69B